{"id":"https://openalex.org/W1966367001","doi":"https://doi.org/10.1038/mt.2011.242","title":"Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11","display_name":"Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11","publication_year":2011,"publication_date":"2011-11-15","ids":{"openalex":"https://openalex.org/W1966367001","doi":"https://doi.org/10.1038/mt.2011.242","mag":"1966367001","pmid":"https://pubmed.ncbi.nlm.nih.gov/22086234","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3272483"},"language":"en","primary_location":{"id":"doi:10.1038/mt.2011.242","doi":"https://doi.org/10.1038/mt.2011.242","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2011.242","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1038/mt.2011.242","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101145932","display_name":"Han Hsi Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Han Hsi Wong","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036858705","display_name":"Guozhong Jiang","orcid":"https://orcid.org/0000-0001-6306-726X","observed_orcids":["https://orcid.org/0000-0001-6306-726X"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Guozhong Jiang","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111874601","display_name":"Rathi Gangeswaran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rathi Gangeswaran","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100604929","display_name":"Pengju Wang","orcid":"https://orcid.org/0000-0002-1046-6360","observed_orcids":["https://orcid.org/0000-0002-1046-6360"]},"institutions":[{"id":"https://openalex.org/I38877650","display_name":"Zhengzhou University","ror":"https://ror.org/04ypx8c21","country_code":"CN","type":"education","lineage":["https://openalex.org/I38877650"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Pengju Wang","raw_affiliation_strings":["Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I38877650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116548937","display_name":"Jiwei Wang","orcid":"https://orcid.org/0009-0007-2966-8935","observed_orcids":["https://orcid.org/0009-0007-2966-8935"]},"institutions":[{"id":"https://openalex.org/I38877650","display_name":"Zhengzhou University","ror":"https://ror.org/04ypx8c21","country_code":"CN","type":"education","lineage":["https://openalex.org/I38877650"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiwei Wang","raw_affiliation_strings":["Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I38877650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100680646","display_name":"Ming Yuan","orcid":"https://orcid.org/0000-0003-3761-3073","observed_orcids":["https://orcid.org/0000-0003-3761-3073"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ming Yuan","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027425392","display_name":"Hexiao Wang","orcid":"https://orcid.org/0000-0001-5191-0643","observed_orcids":["https://orcid.org/0000-0001-5191-0643"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hexiao Wang","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006770521","display_name":"Vipul Bhakta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vipul Bhakta","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heike M\u00fcller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Heike M\u00fcller","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025477800","display_name":"Nicholas Robert Lemoine","orcid":"https://orcid.org/0000-0001-8675-058X","observed_orcids":["https://orcid.org/0000-0001-8675-058X"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I38877650","display_name":"Zhengzhou University","ror":"https://ror.org/04ypx8c21","country_code":"CN","type":"education","lineage":["https://openalex.org/I38877650"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["CN","GB"],"is_corresponding":true,"raw_author_name":"Nicholas R Lemoine","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I38877650"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079279782","display_name":"Yaohe Wang","orcid":"https://orcid.org/0000-0003-2367-6313","observed_orcids":["https://orcid.org/0000-0003-2367-6313"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I38877650","display_name":"Zhengzhou University","ror":"https://ror.org/04ypx8c21","country_code":"CN","type":"education","lineage":["https://openalex.org/I38877650"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["CN","GB"],"is_corresponding":true,"raw_author_name":"Yaohe Wang","raw_affiliation_strings":["Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Sino-British Research Centre for Molecular Oncology, Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I38877650"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5025477800","https://openalex.org/A5079279782"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I38877650","https://openalex.org/I4405264518"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.7965,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.71597958,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"20","issue":"2","first_page":"306","last_page":"316"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11048","display_name":"Bacteriophages and microbial interactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2303","display_name":"Ecology"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9269999861717224},{"id":"https://openalex.org/keywords/adenovirus-type-11","display_name":"adenovirus type 11","score":0.9279999732971191},{"id":"https://openalex.org/keywords/adenovirus-type-5","display_name":"adenovirus type 5","score":0.9589999914169312},{"id":"https://openalex.org/keywords/cd46-receptor","display_name":"CD46 receptor","score":0.8130000233650208},{"id":"https://openalex.org/keywords/viral-receptor-expression","display_name":"viral receptor expression","score":0.5870000123977661},{"id":"https://openalex.org/keywords/viral-dna-replication","display_name":"viral DNA replication","score":0.8650000095367432},{"id":"https://openalex.org/keywords/virus-infectivity","display_name":"viral infectivity","score":0.6480000019073486},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.753000020980835},{"id":"https://openalex.org/keywords/cancer-cell-sensitivity","display_name":"tumor cell sensitivity","score":0.40400001406669617}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.7498500347137451},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5988717675209045},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5247466564178467},{"id":"https://openalex.org/C111936080","wikidata":"https://www.wikidata.org/wiki/Q913367","display_name":"Enhancer","level":4,"score":0.4825553297996521},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4422389268875122},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.41851308941841125},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3396684527397156},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.27283775806427},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.25151753425598145},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.21859166026115417},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.101125568151474}],"mesh":[{"descriptor_ui":"D000256","descriptor_name":"Adenoviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003588","descriptor_name":"Cytopathogenic Effect, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004742","descriptor_name":"Enhancer Elements, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011401","descriptor_name":"Promoter Regions, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014158","descriptor_name":"Transcription, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017500","descriptor_name":"Adenovirus E1A Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D036022","descriptor_name":"Capsid Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D036022","descriptor_name":"Capsid Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050130","descriptor_name":"Oncolytic Virotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050504","descriptor_name":"Oncolytic Viruses","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051301","descriptor_name":"Desmoglein 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051916","descriptor_name":"Membrane Cofactor Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/mt.2011.242","doi":"https://doi.org/10.1038/mt.2011.242","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2011.242","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3272483","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3272483","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther","raw_type":"Text"},{"id":"pmid:22086234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22086234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/mt.2011.242","doi":"https://doi.org/10.1038/mt.2011.242","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2011.242","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2768287746","display_name":null,"funder_award_id":"A6251","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G4999457862","display_name":null,"funder_award_id":"C633-A6253/A6251","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G6222726446","display_name":null,"funder_award_id":"A6253","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8155851166","display_name":null,"funder_award_id":"12008","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1971765707","https://openalex.org/W1979745197","https://openalex.org/W1981755236","https://openalex.org/W1983200566","https://openalex.org/W1992351692","https://openalex.org/W2001424862","https://openalex.org/W2003145275","https://openalex.org/W2007281794","https://openalex.org/W2008193013","https://openalex.org/W2011733836","https://openalex.org/W2012714016","https://openalex.org/W2015438886","https://openalex.org/W2046318087","https://openalex.org/W2050486788","https://openalex.org/W2059519404","https://openalex.org/W2059771582","https://openalex.org/W2067613463","https://openalex.org/W2080421046","https://openalex.org/W2084979979","https://openalex.org/W2086025824","https://openalex.org/W2091376729","https://openalex.org/W2092037848","https://openalex.org/W2092216600","https://openalex.org/W2102128760","https://openalex.org/W2110871523","https://openalex.org/W2119354849","https://openalex.org/W2120963951","https://openalex.org/W2133355048","https://openalex.org/W2141143959","https://openalex.org/W2150881149","https://openalex.org/W2151029201","https://openalex.org/W2159716826","https://openalex.org/W2162023932","https://openalex.org/W2164806280","https://openalex.org/W2166104139","https://openalex.org/W2310488299","https://openalex.org/W6698575153"],"related_works":["https://openalex.org/W257508904","https://openalex.org/W4234025036","https://openalex.org/W4256537555","https://openalex.org/W4249876490","https://openalex.org/W2122312952","https://openalex.org/W1993938068","https://openalex.org/W4391277136","https://openalex.org/W1497491139","https://openalex.org/W2019534018","https://openalex.org/W4205844017"],"abstract_inverted_index":{"Oncolytic":[0],"adenoviruses":[1],"based":[2],"on":[3,105],"serotype":[4],"5":[5],"(Ad5)":[6],"have":[7,102],"several":[8],"shortcomings,":[9],"including":[10],"the":[11,46,62,79,92,118,146,182,189],"downregulation":[12],"of":[13,21,45,61,81,156,191],"its":[14],"receptor":[15,48],"in":[16,51,130,171,174,180],"cancer":[17,39,186],"cells,":[18,135,187],"high":[19],"prevalence":[20],"neutralizing":[22],"antibodies":[23],"and":[24,112,140,164,173,184],"hepatotoxicity.":[25],"Another":[26],"adenoviral":[27],"serotype,":[28],"Ad11,":[29],"could":[30,194],"overcome":[31],"these":[32],"obstacles.":[33],"Here,":[34],"we":[35],"show":[36],"that":[37,76,120,155,193],"human":[38],"cell":[40,63],"lines":[41,64],"express":[42],"higher":[43],"levels":[44,101,163],"Ad11":[47,82,96,98,128,137],"CD46,":[49],"resulting":[50],"much":[52],"better":[53],"infectivity":[54],"than":[55,70],"Ad5.":[56,157],"Surprisingly,":[57],"only":[58],"36%":[59],"(9/25)":[60],"were":[65,142],"more":[66],"sensitive":[67],"to":[68,71,95,126],"Ad11-":[69],"Ad5-mediated":[72],"cytotoxicity.":[73],"Investigations":[74],"revealed":[75],"it":[77],"was":[78,152,178],"transcription":[80,123],"E1A,":[83],"not":[84],"CD46":[85],"expression":[86],"or":[87,149],"virus":[88],"infectivity,":[89],"which":[90],"determined":[91],"cell's":[93],"sensitivity":[94],"killing.":[97],"E1A":[99,122,147,161],"mRNA":[100,162],"an":[103],"effect":[104,177],"viral":[106],"DNA":[107],"replication,":[108,165],"structural":[109],"protein":[110],"synthesis":[111],"infectious":[113],"particle":[114],"production.":[115],"To":[116],"test":[117],"hypothesis":[119],"increased":[121,160],"would":[124],"lead":[125],"improved":[127],"replication":[129],"Ad5-sensitive":[131,183],"(but":[132],"Ad11-less":[133],"sensitive)":[134],"two":[136],"mutants":[138],"(Ad11-Ad5-P":[139],"Ad11-Ad5-EP)":[141],"constructed":[143],"where":[144],"either":[145],"promoter":[148],"enhancer-promoter,":[150],"respectively,":[151],"replaced":[153],"by":[154,198],"Ad11-Ad5-EP":[158],"demonstrated":[159],"together":[166],"with":[167],"enhanced":[168],"oncolytic":[169],"potency":[170],"vitro":[172],"vivo.":[175],"This":[176],"found":[179],"both":[181],"Ad11-sensitive":[185],"broadening":[188],"range":[190],"tumors":[192],"be":[195],"effectively":[196],"killed":[197],"Ad11-Ad5-EP.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}